查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009312

寵物保健產品市場規模、佔有率、趨勢和預測：按動物種類、產品類型、最終用戶和地區分類，2026-2034 年。

Companion Animal Health Market Size, Share, Trends and Forecast by Animal Type, Product, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年全球伴侶動物醫療保健市場規模為293.7億美元。展望未來，IMARC Group預測，該市場將以7.03%的複合年成長率從2026年成長至2034年，到2034年達到593.7億美元。目前，北美市場處於領先地位，預計2025年將佔據40.5%的市場。該地區受益於許多因素，例如寵物擁有率高、獸醫醫療保健基礎設施完善、寵物保險普及以及政府對動物醫療保健標準的大力支持，這些因素共同維持了強勁的需求，並支撐了伴侶動物醫療保健行業的市場佔有率。

受人口、經濟和科技等多面向因素的共同推動，全球伴侶動物醫療保健市場正經歷強勁成長。寵物日益“擬人化”，從根本上改變了寵物飼主對待動物醫療保健的方式，越來越多的人將伴侶動物視為家庭成員，並尋求高品質的醫療服務。已開發經濟體和新興經濟體可支配收入的成長，提高了人們在預防保健、診斷和專科治療方面的投資意願。人們對通用感染疾病的認知不斷提高，進一步凸顯了定期獸醫護理和疫苗接種計劃的重要性。獸醫診斷技術的進步，包括就地檢驗設備和先進影像系統，使得疾病的早期發現和更準確成為可能。獸醫遠端醫療服務的擴展，改善了服務不足地區獲得醫療保健諮詢的機會。此外，寵物飼養量的激增，尤其是在全球疫情期間和之後，從根本上增加了伴侶動物的總數，從而為健康相關產品和服務創造了持續成長的需求基礎，這預示著全球伴侶動物醫療保健市場將呈現積極的成長前景。

由於多種因素，美國正崛起為伴侶動物健康市場的重要區域。美國擁有全球規模最大的伴侶動物群之一，從都市區到鄉村，數百萬家庭都飼養寵物。遍佈全國的執照獸醫醫院、診所和專科醫療中心網路為服務提供奠定了堅實的基礎。美國農業部和食品藥物管理局（FDA）等聯邦機構的監管體系確保了藥品核准和獸藥產品安全性的嚴格標準。寵物保險的普及使更多飼主能夠負擔得起先進的治療方案，從而鼓勵他們更頻繁地帶寵物就診並採用專科治療方法。尤其值得一提的是，美國在新型生技藥品和標靶治療的研發投入尤為活躍。

伴侶動物健康市場趨勢：

寵物保險的投保人數正在迅速增加。

在主要市場，寵物保險參保率的不斷攀升正在顯著改變伴侶動物獲得醫療保健的方式。隨著複雜手術和慢性病管理的獸醫費用持續上漲，越來越多的飼主開始利用保險計畫來應對意外的醫療支出。這種轉變促使人們更多地使用先進的診斷、外科手術和專家會診，而這些服務原本可能因為費用限制而被忽略。保險公司正日益專注於拓展產品範圍，涵蓋從遺傳疾病到牙科護理和行為療法等各種疾病。在北美和歐洲部分地區，雇主提供的寵物保險福利不斷擴大，進一步推動了工作年齡層寵物的投保。能夠實現無縫理賠管理和保險計劃比較的技術平台正在降低寵物參保的門檻。

獸用生物製劑的進展

獸用生物製劑領域正經歷快速的科學發展時期，這主要得益於研發投入的增加以及生物技術平台在動物醫學領域的應用。基於已在人類醫療保健領域得到驗證的調查方法，利用傳訊RNA技術的新型疫苗製劑正被研發用於伴侶動物。單株抗體療法正逐步進入獸醫領域，為犬貓的過敏性皮膚炎和骨關節炎等疾病提供標靶治療方案。與傳統藥物相比，這些療法具有顯著優勢，包括高特異性、良好的安全性以及持久的療效。北美和歐洲的監管機構正在簡化高優先級獸用生物製藥的核准流程，從而縮短創新產品的上市時間。產學合作正在加速從研究成果到商業性化解決方案的轉化。不斷擴充的獸用生物生技藥品產品線反映了投資者日益成長的信心，全球領先的動物用藥品公司正將大量研發預算投入該領域。這一趨勢代表了治療模式的重大演變，也反映了伴侶動物健康市場生技藥品細分領域在短期內光明的前景。

拓展獸醫遠端保健服務

獸醫遠端保健正逐漸成為伴侶動物醫療保健領域的變革性舉措，它不僅彌合了地域和經濟上的就醫鴻溝，還提高了醫療服務的效率。隨著數位化趨勢的興起，連接寵物飼主和合格獸醫的數位平台，例如視訊諮詢、聊天和非同步通訊等，正在迅速發展。這些服務在初步分流、術後後續觀察、處方箋管理和行為諮詢方面特別有效，從而減少了非緊急情況下對線下就診的需求。穿戴式寵物健康監測設備的整合，能夠追蹤生命徵象、活動量和睡眠模式，從而實現數據驅動的遠端健康評估。獸醫院正擴大採用混合護理模式，將院內服務與數位化管道結合，以提高客戶參與度和治療依從性。在一些關鍵市場，獸醫遠端醫療醫療的監管框架正在日趨完善，為獸醫和技術提供者提供了更清晰的營運指導。對獸醫專用遠距遠端醫療基礎設施（包括人工智慧分診工具和基於雲端的醫療記錄整合）的投入不斷增加，進一步提升了平台的成熟度和擴充性。這表明，基於遠端醫療的照護模式在全球伴侶動物健康市場具有極其廣闊的成長前景。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球寵物保健產品市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依動物類型分類

  • 狗
  • 貓
  • 馬
  • 其他

第7章 市場區隔：依產品分類

  • 疫苗
  • 製藥
  • 飼料添加劑
  • 診斷
  • 其他

第8章 市場區隔：依最終用戶分類

  • 即時檢測/院內檢測
  • 獸醫醫院和診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Agrolabo SpA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra
    • Elanco
    • Greencross Vets
    • IDEXX Laboratories, Inc.
    • Indian Immunologicals Ltd.
    • Norbrook
    • Vetoquinol
    • Virbac
    • Zoetis Services LLC
Product Code: SR112026A5482

The global companion animal health market size was valued at USD 29.37 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 59.37 Billion by 2034, exhibiting a CAGR of 7.03% from 2026-2034. North America currently dominates the market, holding a market share of 40.5% in 2025. The region benefits from high pet ownership rates, advanced veterinary infrastructure, widespread pet insurance adoption, and robust government support for animal healthcare standards, which collectively sustain strong demand and underpin the companion animal health market share.

The global companion animal health market is experiencing robust growth driven by a convergence of demographic, economic, and scientific factors. The increasing trend of pet humanization has fundamentally transformed how owners approach animal healthcare, with more individuals treating companion animals as family members and seeking premium medical services. Rising disposable incomes across both developed and emerging economies have expanded the willingness to invest in preventive care, diagnostics, and specialized treatments. Growing awareness of zoonotic diseases has further reinforced the importance of regular veterinary care and vaccination programs. Technological advancements in veterinary diagnostics, including point-of-care testing devices and advanced imaging systems, are enabling earlier and more accurate disease detection. The expansion of veterinary telemedicine services has improved accessibility to healthcare advice in underserved regions. Additionally, the surge in pet adoption, particularly during and after the global pandemic period, has structurally increased the companion animal population, thereby creating a sustained and expanding base of demand for health products and services, reflecting favorable companion animal health market growth prospects globally.

The United States has emerged as a major region in the companion animal health market owing to many factors. The country hosts one of the largest companion animal populations in the world, with pets present in millions of households across urban and rural settings. An extensive network of licensed veterinary clinics, animal hospitals, and specialty care centers forms a strong foundation for service delivery. Federal oversight through agencies such as the US Department of Agriculture and the Food and Drug Administration ensures rigorous standards for pharmaceutical approvals and veterinary product safety. The widespread availability of pet insurance coverage has made advanced treatments financially accessible to a broader segment of pet owners, encouraging more frequent veterinary visits and uptake of specialized therapies. Research and development investments in novel biologics and targeted therapeutics are particularly strong within the country.

COMPANION ANIMAL HEALTH MARKET TRENDS:

Surge in Pet Insurance Adoption

The rising uptake of pet insurance across major markets is significantly reshaping how companion animal healthcare is financed and accessed. As veterinary costs for complex procedures and chronic disease management continue to escalate, more pet owners are turning to insurance plans to manage unexpected medical expenses. This shift is encouraging higher utilization of advanced diagnostics, surgical interventions, and specialist consultations that might otherwise be foregone due to cost constraints. Insurers are increasingly tailoring products to cover a broad range of conditions, from hereditary disorders to dental care and behavioral therapy. The expansion of employer-sponsored pet insurance benefits in North America and parts of Europe has further accelerated enrollment among working-age adults. Technological platforms enabling seamless claims management and policy comparison have lowered barriers to insurance uptake.

Advancements in Veterinary Biologics

The veterinary biologics segment is undergoing a period of rapid scientific advancement, driven by increased research investment and the application of biotechnology platforms to animal health. Novel vaccine formulations leveraging messenger RNA technology are being explored for companion animals, building on methodologies validated during human healthcare applications. Monoclonal antibody therapies have entered the veterinary therapeutics space, offering targeted treatment options for conditions such as allergic dermatitis and osteoarthritis in dogs and cats. These therapies offer compelling advantages over traditional pharmaceuticals, including high specificity, favorable safety profiles, and sustained duration of action. Regulatory agencies in North America and Europe have streamlined approval pathways for priority veterinary biologics, reducing time-to-market for innovative products. Academic-industry collaborations are accelerating the translation of research into commercially viable solutions. The growing pipeline of veterinary biologics reflects broader investment confidence, with major global animal health companies allocating substantial R&D budgets to this area. This trajectory signals a meaningful evolution in treatment paradigms, reflecting positive companion animal health market outlook for the biologics subsegment in the near term.

Expanding Veterinary Telehealth Services

Veterinary telehealth has emerged as a transformative channel within companion animal healthcare, bridging geographic and economic access gaps while enhancing the efficiency of care delivery. Digital platforms connecting pet owners with licensed veterinarians via video consultation, chat, and asynchronous messaging have proliferated following the accelerated digital adoption trends observed in recent years. These services are particularly valuable for initial triage, post-operative monitoring, prescription management, and behavioral consultations, reducing the need for in-person visits for non-emergency cases. The integration of wearable health monitoring devices for pets, capable of tracking vital signs, activity levels, and sleep patterns, is enabling data-driven remote health assessments. Veterinary practices are increasingly adopting hybrid care models that combine in-clinic services with digital touchpoints to improve client engagement and treatment compliance. Regulatory frameworks governing telehealth in veterinary medicine are maturing across key markets, providing greater operational clarity for practitioners and technology providers alike. Growing investment in purpose-built veterinary telehealth infrastructure, including AI-assisted triage tools and cloud-based medical record integration, is further accelerating platform sophistication and scalability. This reflects compelling companion animal health market forecast potential for telehealth-enabled care models globally.

COMPANION ANIMAL HEALTH INDUSTRY SEGMENTATION:

Analysis by Animal Type:

  • Dogs
  • Cats
  • Equine
  • Others

Dogs hold 45.0% of the market share. Dogs represent the largest animal type segment within the companion animal health market, reflecting their status as the most widely owned pet species globally. The deep emotional bonds formed between dogs and their owners drive significant spending on preventive care, vaccinations, diagnostics, and treatment of chronic conditions such as arthritis, dermatological disorders, and diabetes. The sheer diversity of dog breeds, each with distinct health predispositions, creates strong demand for a wide array of specialized pharmaceutical and biological products. Growing awareness of preventive wellness programs, including regular screenings and parasite control, has further elevated healthcare engagement among dog owners. The aging dog population in developed markets is contributing to rising demand for senior-specific health solutions, including joint supplements, pain management therapies, and oncology treatments. Furthermore, the premiumization trend in pet care has led owners to seek high-quality, evidence-based medical interventions for their dogs, sustaining consistent revenue growth within this segment and reinforcing its dominant position across the companion animal health industry worldwide.

Analysis by Product:

  • Vaccines
  • Pharmaceuticals
  • Feed Additives
  • Diagnostics
  • Others

Pharmaceuticals lead the market with a share of 41.0%. Pharmaceuticals represent the cornerstone of companion animal health management, encompassing a broad range of prescription and over-the-counter drugs designed to prevent, treat, and manage diseases across multiple species. The category includes anti-infectives, anti-parasitics, analgesics, anti-inflammatory agents, dermatological preparations, and endocrine therapies, among others. The growing incidence of lifestyle-related conditions in companion animals, including obesity, diabetes, and cardiovascular disorders linked to sedentary environments and processed diets, has amplified pharmaceutical demand. Enhanced regulatory clarity around veterinary drug approvals has facilitated the entry of new formulations with improved efficacy and safety profiles. The development of species-specific dosage forms and palatability-optimized delivery systems has improved owner compliance and treatment adherence. Expansion into novel therapeutic areas, including oncology, neurology, and immunology, reflects the broadening scope of veterinary pharmaceuticals. Continued investment in generic drug development is also improving affordability and access across diverse economic settings, further solidifying pharmaceuticals as the leading product category in the market.

Analysis by End User:

  • Point-of-care Testing/In-house Testing
  • Veterinary Hospitals and Clinics
  • Others

Veterinary hospitals and clinics dominate the market, with a share of 79.8%. These establishments serve as the primary point of contact between companion animals and professional healthcare services, offering comprehensive diagnostic, therapeutic, and surgical capabilities under one roof. The concentration of advanced medical equipment, specialized staff, and established regulatory compliance standards within these settings makes them the preferred channel for complex health interventions, emergency care, and specialist referrals. Rising pet ownership and the growing willingness of owners to invest in preventive wellness programs have translated into higher foot traffic at veterinary facilities worldwide. The ongoing expansion of corporate veterinary chains and multi-specialty animal hospitals across North America, Europe, and Asia-Pacific has enhanced service capacity and standardization. Veterinary hospitals also serve as key distribution points for prescription pharmaceuticals, vaccines, and therapeutic diets, reinforcing their centrality in the health product supply chain. The growing integration of digital tools for appointment scheduling, electronic medical records, and remote monitoring within clinical settings is further strengthening their operational efficiency and competitive position.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for 40.5% of the share, holds the leading position in the market. The dominance is further fueled by the exceptionally high pet ownership rate in the region, with a considerable number of households in the United States and Canadian territories boasting the presence of companion animals. The presence of thousands of licensed veterinary clinics, specialty hospitals, and emergency care facilities ensures the provision of top-notch health management services to companion animals in the region. The robust institutional frameworks in place to guide the approval of veterinary products and the management of animal welfare add to the dominance of North America in the companion animal health management industry. The pet insurance culture has increased the affordability of top-notch medical services to pets, allowing for the increased use of diagnostics, specialty treatments, and high-end pharmaceutical products. The high level of consumer expenditure in the companion animal health and wellness industry is a reflection of the culture in the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES COMPANION ANIMAL HEALTH MARKET ANALYSIS

The United States holds 95.20% of companion animal health in North America. The United States represents the single largest country-level market within the global companion animal health landscape, driven by a combination of structural, cultural, and regulatory factors that consistently support elevated healthcare spending for pets. The country benefits from one of the most extensive veterinary care networks in the world, encompassing general practice clinics, specialty and emergency hospitals, and academic veterinary medical centers engaged in cutting-edge research. Government agencies including the U.S. Department of Agriculture's Center for Veterinary Biologics and the FDA's Center for Veterinary Medicine maintain rigorous oversight frameworks that foster consumer confidence in approved health products. The rapid growth of the pet insurance sector has meaningfully expanded access to costly procedures, including orthopedic surgeries, oncology treatments, and advanced diagnostics. Consumer spending on companion animal health in the United States continues to grow year-on-year, fueled by humanization trends and a shift toward preventive care philosophies. Strong e-commerce channels for pet health products, alongside growing adoption of digital veterinary health platforms, further companion animal health market trends across the United States.

EUROPE COMPANION ANIMAL HEALTH MARKET ANALYSIS

Europe constitutes a significant and steadily expanding contributor to the global companion animal health market, supported by high pet ownership rates, progressive animal welfare legislation, and a well-established veterinary services sector. The United Kingdom, Germany, France, Italy, and Spain represent the largest national markets within the region, each characterized by dense veterinary clinic networks and sophisticated distribution systems for animal health products. European regulatory bodies, including the European Medicines Agency, apply stringent standards to veterinary pharmaceutical approvals, ensuring product quality and efficacy across member states. The growing adoption of preventive healthcare practices, including routine vaccination, parasite control, and dental care programs, reflects a cultural shift toward proactive animal health management. Rising elderly pet populations in several Western European countries are creating demand for geriatric care solutions, including mobility aids, pain management therapies, and specialized nutritional products.

ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET ANALYSIS

Asia-Pacific represents the fastest-growing regional market for companion animal health, driven by rapidly rising pet ownership in urbanizing economies including China, Japan, South Korea, India, and Australia. Expanding middle-class populations with increasing disposable incomes are embracing companion animals as lifestyle additions, fueling demand for veterinary services and health products. Urbanization and changing family structures, particularly the growing prevalence of single-person and childless households, have reinforced the emotional significance attached to pets across the region. Veterinary infrastructure is expanding rapidly, with significant investments in clinic networks, pharmaceutical distribution, and diagnostic laboratories in key markets. Government initiatives promoting animal disease surveillance and vaccination campaigns are improving formal healthcare penetration for companion animals.

LATIN AMERICA COMPANION ANIMAL HEALTH MARKET ANALYSIS

Latin America represents an emerging growth opportunity within the global companion animal health market, with Brazil and Mexico serving as the primary drivers of regional demand. Rising pet ownership rates, particularly in urban centers, and growing awareness of animal welfare standards are elevating healthcare spending for companion animals across the region. Expanding middle-class segments are increasingly adopting preventive veterinary care practices, including routine vaccinations and parasite management. The rollout of regional veterinary hospital chains and improved pharmaceutical distribution networks is broadening access to quality health products.

MIDDLE EAST AND AFRICA COMPANION ANIMAL HEALTH MARKET ANALYSIS

The Middle East and Africa region represents an emerging and gradually evolving segment within the companion animal health market, driven by rising urbanization, increasing pet adoption in metropolitan areas, and growing awareness of formal veterinary care. The Gulf Cooperation Council countries, particularly the United Arab Emirates and Saudi Arabia, are demonstrating the strongest demand growth, supported by affluent urban populations and a cultural shift toward pet ownership. Government initiatives across several African nations to control zoonotic diseases are indirectly stimulating investment in companion animal health infrastructure.

COMPETITIVE LANDSCAPE:

The global companion animal health market is characterized by a moderately consolidated competitive profile, with various multinational corporations dominating the market along with a significant number of mid-size companies that specialize in the field of animal health. The major companies in the field continue to invest heavily in research and development activities to enhance their product offerings in the fields of pharmaceuticals, vaccines, and diagnostics, among others. Mergers and acquisitions, partnerships, and collaborations have been significant mechanisms adopted by companies to compete with their peers in the field of animal health products. The various challenges faced by the companies, including the high cost of clinical trials for the development of novel biological products, the high cost of generic products, and the high cost of complying with various regulations in various markets, have been influencing the overall competitive dynamics of the market. The companies are also focusing on the development of precision medicine platforms, data-based disease management platforms, and direct-to-consumer digital initiatives to compete with their peers in the field of animal health products. Partnerships between research institutions and contract development organizations have been driving the overall innovation-based competition in the field of animal health products.

The report provides a comprehensive analysis of the competitive landscape in the companion animal health market with detailed profiles of all major companies, including:

  • Agrolabo S.p.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra
  • Elanco
  • Greencross Vets
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Norbrook
  • Vetoquinol
  • Virbac
  • Zoetis Services LLC

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the companion animal health market?

2. What is the future outlook of the companion animal health market?

3. What are the key factors driving the companion animal health market?

4. Which region accounts for the largest companion animal health market share?

5. Which are the leading companies in the global companion animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Companion Animal Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Dogs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cats
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Equine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Feed Additives
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Point-of-care Testing/In-house Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Veterinary Hospitals and Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agrolabo S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ceva Sante Animale
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Dechra
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Elanco
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Greencross Vets
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 IDEXX Laboratories, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Indian Immunologicals Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Norbrook
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Vetoquinol
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Services LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Companion Animal Health Market: Major Drivers and Challenges
  • Figure 2: Global: Companion Animal Health Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Companion Animal Health Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Companion Animal Health Market: Breakup by Animal Type (in %), 2025
  • Figure 5: Global: Companion Animal Health Market: Breakup by Product (in %), 2025
  • Figure 6: Global: Companion Animal Health Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Companion Animal Health Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Companion Animal Health (Dogs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Companion Animal Health (Dogs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Companion Animal Health (Cats) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Companion Animal Health (Cats) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Companion Animal Health (Equine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Companion Animal Health (Equine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Companion Animal Health (Other Animal Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Companion Animal Health (Other Animal Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Companion Animal Health (Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Companion Animal Health (Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Companion Animal Health (Pharmaceuticals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Companion Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Companion Animal Health (Feed Additives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Companion Animal Health (Feed Additives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Companion Animal Health (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Companion Animal Health (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Companion Animal Health (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Companion Animal Health (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Companion Animal Health (Point-of-care Testing/In-house Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Companion Animal Health (Point-of-care Testing/In-house Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Companion Animal Health (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Companion Animal Health (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Companion Animal Health (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Companion Animal Health (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Companion Animal Health Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Companion Animal Health Industry: SWOT Analysis
  • Figure 82: Global: Companion Animal Health Industry: Value Chain Analysis
  • Figure 83: Global: Companion Animal Health Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Companion Animal Health Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Companion Animal Health Market Forecast: Breakup by Animal Type (in Million USD), 2026-2034
  • Table 3: Global: Companion Animal Health Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 4: Global: Companion Animal Health Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Companion Animal Health Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Companion Animal Health Market: Competitive Structure
  • Table 7: Global: Companion Animal Health Market: Key Players